Oklahoma 2024 2024 Regular Session

Oklahoma House Bill HB3574 Introduced / Bill

Filed 01/18/2024

                     
 
 
Req. No. 9020 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 59th Legislature (2024) 
 
HOUSE BILL 3574 	By: Pae 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to public health and safety; amending 
63 O.S. 2021, Section 1 -1432.4, which relates to the 
Oklahoma Kratom Consumer Protecti on Act; requiring 
additional information when labeling kratom products; 
and providing an effective date . 
 
 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2021, Section 1 -1432.4, is 
amended to read as follows: 
Section 1-1432.4  A. A vendor shall not prepare, distribute, 
sell or expose for sale any of the f ollowing: 
1.  A kratom product that is adulterated with a nonkra tom 
substance.  A kratom product is adulterated with a nonkratom 
substance if the kratom product is mixed or packed with a nonkratom 
substance and that substance affects the quality or streng th of the 
kratom product to such a degree as to render the kratom product 
injurious to a consumer;   
 
 
Req. No. 9020 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2.  A kratom product that is contaminated with a dangerou s 
nonkratom substance.  A kratom product is contaminated with a 
dangerous nonkratom substance if th e kratom product contains a 
substance that is not safe for human c onsumption; 
3.  A kratom product containing a level of 7 -hydroxymitragynine 
in the alkaloid fraction that is greater than two percent (2%) of 
the alkaloid composition of the product; 
4.  A kratom product containing any synthetic alkaloid including 
synthetic mitragynine, synthetic 7 -hydroxymitragynine or any other 
synthetically derived compounds of the kratom plant; or 
5.  A kratom product containing any controlled substance listed 
in the Uniform Controlled Dangerous Substances Act, unless the 
product is compounded by a licensed pharmacist with the controlled 
substance dispensed in accordance wit h a valid prescription. 
B.  Kratom products shall be accompanied by a label, or a quick 
response (QR) code on the product label linked to a website, bearing 
the following information prior to its sale in this state: 
1.  A list of the ingredients, which shall include the common or 
usual name of each ingredient used in the manufacture of the 
product, listed in descending order of predominance; 
2.  That the sale or trans fer of kratom to a person under 
eighteen (18) years of age is prohi bited; 
3.  The amount of mitragynine and 7-hydroxymitragynine contained 
in the product;   
 
 
Req. No. 9020 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
4.  The amount of mitragyni ne and 7-hydroxymitragynine contained 
in packaging for the product; 
5.  The name and the principal street address of the vendor or 
the person responsible for distrib uting the product; 
6. The suggested Clear and adequate directions for the 
consumption and safe and effective use of the such product, 
including the recommended se rving size, the number of serving s in 
the container, the num ber of servings that can be safe ly consumed in 
a day, and the time frame within which safe consumption should 
occur; and 
7.  Any precautionary state ments as to the safety and 
effectiveness of the product , including a warning that a consumer 
should consult his or her physician on questio ns about use of 
kratom, and state that the kratom product is not intended to 
"diagnose, treat, cure , or prevent any disease "; and 
8.  A statement that a kratom product label is prohibited from 
making any therapeutic claims unless approved by the United States 
Food and Drug Administration. 
C.  A vendor may not distribute, sell or expose for sale a 
kratom product to an individual under eighteen (18) years of age. 
D.  Upon request by the State Department of Health, the vendor 
shall provide test results from a United States-based testing 
facility to confirm the items listed on the product label.   
 
 
Req. No. 9020 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
SECTION 2.  This act shall become effective November 1, 2024. 
 
59-2-9020 GRS 12/18/23